Cochlear Ltd (COH.AX) stock: key figures, P/E, revenue and dividend

Health Care · Australia · ISIN AU000000COH5

Price
138.68 AUD
Market cap
9.07 bn AUD
P/E (2026)
61.57
P/S (2026)
3.89
Dividend yield
4.60 %
Net margin
6.30 %
Return on equity (ROE)
8.45 %
Return on assets (ROA)
5.65 %

Cochlear Ltd financials

Fiscal year20252026
Revenue2.34 bn AUD2.33 bn AUD
Gross profit1.73 bn AUD1.65 bn AUD
EBIT406.00 m AUD301.00 m AUD
Net income388.00 m AUD147.00 m AUD
Diluted EPS – continuing operations5.93 AUD2.25 AUD

Full history since 1996, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

Sign up for freeOpen interactive view

About Cochlear Ltd

Cochlear Limited provides implantable hearing solutions in the Americas, Europe, the Middle East, Africa, and Asia Pacific. It offers cochlear implant systems; replacement sound processors, accessories, and other services; bone conduction systems and replacement sound processors; and recipient support tools. The company also provides Cochlear connected care solutions, such as Cochlear Nucleus SmartNav System; Cochlear Custom Sound Pro Fitting Software; Cochlear Remote Assist; Cochlear Remote Check; and Cochlear Link. It offers its products and services under the Cochlear, Nucleus, Nexa, Osia, and Cochlear Baha brands. Cochlear Limited was founded in 1981 and is headquartered in Sydney, Australia.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 20.10.2026. Details in the risk notice.

Cochlear Ltd stock (COH.AX): P/E, revenue, dividend | finmetric